Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

Show full CV Hide full CV

Latest news & insights

Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2023

1 February 2023

by multiple authors

Click here to find out more
Life sciences & healthcare

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

18 April 2024
In-depth analysis

by Dr. Stefanie Greifeneder and Irina Rebin

Click here to find out more
Corporate/M&A & capital markets

Advising Gresham Technologies on its sale to Alliance Bidco

12 April 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Subway® on its partnership with McWin for the expansion of the Subway® franchise network in France, Belgium, Luxembourg and the Czech Republic

28 March 2024

by multiple authors

Click here to find out more

Meet me at

There are no upcoming events